India detected 3,832 new leprosy cases among children in 2025-26, against a National Leprosy Eradication Programme (NLEP) target of 2,000 for the year, a report of 4 October 2026 showed. That is 91.6% above the target.
Thirty-seven of those children already had Grade-2 Disability (visible deformity) when diagnosed, although the programme's objective is zero disability among new child cases.
India detected 91,783 new leprosy cases in all in 2025-26, the highest of any country; the prevalence rate was 0.56 per 10,000 population.
The National Strategic Plan and Roadmap for Leprosy 2023-27 aims to interrupt transmission at district level by 2027, which is defined as zero new child cases for five consecutive years.
Leprosy incubates for years, so a case in a child means infection was passed on recently. Grade-2 Disability is visible deformity, which appears only after long untreated disease. A child with G2D therefore shows both ongoing transmission and late detection.
Simple Analogy: Fresh footprints show someone passed recently; deep ones show nobody noticed for a long time.
Early detection and free treatment of leprosy, prevention of disability and removal of stigma.
Key: Began in 1983 with the introduction of multidrug therapy, replacing the National Leprosy Control Programme of 1955. It is a centrally sponsored scheme under the National Health Mission, Ministry of Health and Family Welfare.
Interrupt transmission at district level by 2027.
Key: A district has interrupted transmission when it reports zero new child cases for at least five consecutive years; it then moves to elimination of disease, defined as zero new cases for at least three consecutive years. Aligned with WHO's Global Leprosy Strategy 2021-2030.
Protect healthy contacts of a leprosy patient and break the chain of transmission.
Key: Coverage of eligible contacts rose from 71% in 2019-20 to 92% in 2024-25.
Door-to-door search for hidden cases in high-endemic areas.
Key: Held twice a year in high-endemic states; 27,428 new cases were confirmed through it in 2024-25. ASHA-Based Surveillance for Leprosy Suspects (ABSULS) does routine case finding at village level.
Web-based portal for recording, reporting and monitoring leprosy patients and drug stocks.
Key: Launched on 30 January 2023, National Anti-Leprosy Day.
Uniform three-drug treatment.
Key: From 1 April 2025, paucibacillary (PB) patients also receive three drugs, as multibacillary (MB) patients already did. Multidrug therapy combines rifampicin, dapsone and clofazimine.
Runs the NLEP and issues its guidelines and annual data.
Supplies multidrug therapy free of cost, publishes the annual Global Leprosy Update in its Weekly Epidemiological Record and classes leprosy as a Neglected Tropical Disease.
National Leprosy Control Programme launched, based on dapsone monotherapy.
WHO endorses multidrug therapy as the standard treatment.
Multidrug therapy introduced in India; the programme becomes the National Leprosy Eradication Programme.
World Health Assembly sets the goal of eliminating leprosy as a public health problem by 2000.
India reaches elimination as a public health problem at the national level.
Nikusth 2.0 portal launched on National Anti-Leprosy Day.
Three-drug regimen for both PB and MB patients takes effect in all States and UTs.
WHO publishes the Global Leprosy Update 2025; India reports the most new cases.
National target year for interruption of transmission at district level.
GS Paper 2 > Issues relating to Health; Prelims > Diseases and government programmes
General Awareness > Diseases and their causative organisms; Health programmes
The "PM-ABHIM" scheme is related to which sector?
Answer: Health Infrastructure
Which one of the following statements is not correct?
Answer: Hepatitis B, unlike Hepatitis C, does not have a vaccine.
Visible deformity or damage caused by leprosy, present at the time of diagnosis; a marker of late detection.
Prevalence of less than 1 case per 10,000 population. It does not mean zero cases.
Combination of rifampicin, dapsone and clofazimine that cures leprosy; supplied free through WHO.